Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mRNA targets of Bone Marrow Mesenchymal Stem Cell-derived Microvesicle (BMSC-MV) microRNA cargo represent a diverse set of transcripts regulated by the paracrine activity of stem cells. BMSCs secrete microvesicles that encapsulate a specific profile of microRNAs (miRNAs), which are then delivered to target cells to modulate their biological response (Source: PMC5835590). Upon entry into recipient cells, these miRNAs typically bind to the 3' untranslated regions (UTRs) of specific mRNAs, leading to gene silencing through mRNA degradation or translational inhibition (Source: Nature Reviews Genetics, 2018). This regulatory axis is a primary mechanism by which BMSC-based therapies exert anti-inflammatory, anti-apoptotic, and pro-regenerative effects in diseases such as myocardial infarction, acute kidney injury, and various cancers (Source: Stem Cell Research & Therapy, 2020). Because the term refers to a variable collection of downstream effectors rather than a single protein or nucleic acid sequence, it is characterized as a functional category of targets rather than a discrete therapeutic target. The therapeutic utility of this axis depends on the specific miRNA-mRNA interactions, which are being explored for their potential in precision regenerative medicine.
MicroRNAs within the microvesicles bind to the 3' untranslated regions (UTRs) of target mRNAs, leading to mRNA cleavage, destabilization, or inhibition of translation via the RNA-induced silencing complex (RISC).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mRNA targets of Bone Marrow Mesenchymal Stem Cell-derived Microvesicle (BMSC-MV) microRNA cargo.